Filing Details
- Accession Number:
- 0001415889-24-006170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-01 18:26:17
- Reporting Period:
- 2024-02-28
- Accepted Time:
- 2024-03-01 18:26:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1730430 | Kiniksa Pharmaceuticals Ltd. | KNSA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1464583 | R Michael Megna | C/O Kiniksa Pharmaceuticals, Ltd. Clarendon House 2 Church Street Hamilton D0 HM 11 | Chief Accounting Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Share | Acquisiton | 2024-01-15 | 583 | $12.35 | 17,588 | No | 4 | A | Direct | |
| Class A Common Share | Acquisiton | 2024-02-28 | 5,126 | $8.83 | 22,714 | No | 4 | M | Direct | |
| Class A Common Share | Disposition | 2024-02-28 | 5,126 | $21.79 | 17,588 | No | 4 | S | Direct | |
| Class A Common Share | Acquisiton | 2024-03-01 | 5,645 | $8.83 | 23,233 | No | 4 | M | Direct | |
| Class A Common Share | Acquisiton | 2024-03-01 | 4,014 | $13.88 | 27,247 | No | 4 | M | Direct | |
| Class A Common Share | Disposition | 2024-03-01 | 9,659 | $21.45 | 17,588 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Share | Share Option | Disposition | 2024-02-28 | 5,126 | $0.00 | 5,126 | $8.83 |
| Class A Common Share | Share Option | Disposition | 2024-03-01 | 5,645 | $0.00 | 5,645 | $8.83 |
| Class A Common Share | Share Option | Disposition | 2024-03-01 | 4,014 | $0.00 | 4,014 | $13.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,874 | 2029-09-16 | No | 4 | M | Direct | |
| 229 | 2029-09-16 | No | 4 | M | Direct | |
| 0 | 2028-08-05 | No | 4 | M | Direct |
Footnotes
- The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2023 to January 15, 2024. The acquisition of such shares was exempt pursuant to Rule 16b-3(c).
- This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.56 to $21.90. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.45 to $21.49. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
